Financials
Financial year 2024
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 543
▲ 107% vs 2023
Profit
Growing€ 1.5 million
▲ 11796% vs 2023
Debts
Low€ 1.5 million
▼ 57% vs 2023
Biotec from Lasne, company number BE0414938680, closed financial year 2024 with a result of € 1.5 million after tax. For that financial year Biotec recorded a gross margin of € 543 and equity of € 4.1 million. Compared with financial year 2023, the result moved from € 12,210 to € 1.5 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2025.
What happened at Biotec?
What happened at Biotec in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Nathalie DELWART stepped down as director. NBB
- Olivia DELWART stepped down as director. NBB
- Charles-Emmanuel DELWART stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 1.5 million (▲ 11796% vs 2023). Source: NBB ↗
- Nathalie DELWART became a director. NBB
- Olivia DELWART became a director. NBB
- Charles-Emmanuel DELWART became a director. NBB
- Jean-Marie DELWART stepped down as director. NBB
In short
From € 67,925 profit in 2021 to € 1.5 million profit in 2024.
Paid € 37,855 in corporate taxes since 2021.
Best year ever: 2024, with € 1.5 million profit.
A new publication or filing at Biotec? We notify you, reason included.
Follow BiotecNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Belgocodex SA (78.5%). It owns 30.9% of PHARMACIE DU VERT CHASSEUR, 20.3% of CHEMCOM and 16.8% of DOMAINE D'ARGENTEUIL itself.
Directors
According to the 2024 annual accounts
since 2025 · until 2031
Jean-Marie DELWART
Managing director
· until 2025
since 2025 · until 2031
since 2025 · until 2031
Shareholders
78.5%
Participations
Establishments
Establishment units
Physical locations of this company
Chaussée de Louvain 656
1380 Lasne
Drève Richelle 161 box 10
1410 Waterloo
Active since 6 October 1992
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Details
- Company number
- 0414.938.680
- VAT number
- BE 0414.938.680
- Registered office
- Chaussée de Louvain 656, 1380 Lasne
- Names & denominations
- Biotec
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 July 1975
- Peppol
- Active · Active since 15 Oct 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied